Barriers and Facilitators of Parent-Child Communication in Children With Cancer Predisposition

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age10-24
SponsorSt. Jude Children's Research Hospital

About this trial

Testing children, adolescents, and young adults (CAYA) for a genetic risk for cancer can help with early prevention and detection of cancers through regular follow-ups and medical care. After receiving genetic test results, CAYA may not accurately understand what their results mean, and parents are often unsure about talking with their CAYA about their genetic risk for cancer. By understanding how parents communicate with their CAYA, the investigators can improve future genetic education to reduce cancer risk.

Primary Objectives:

* Identify qualities of parent-CAYA (child, adolescent, and young adults) communication about CAYAs' genomic cancer risk, and their association with CAYAs' psychosocial and prevention outcomes. * Examine the association between sociodemographic, cancer-related, and psychosocial factors and parent-CAYA communication regarding CAYAs' genomic risk for cancer. * Identify barriers and facilitators of parent-CAYA communication regarding CAYAs' genomic risk for cancer.

Eligibility criteria

Qualifiers

Patient aged 10 to 24 years (inclusive)

Patient underwent germline genetic testing with a Pathogenic/Likely Pathogenic (P/LP) variant in a known cancer predisposition gene that increases risk for developing cancer

P/LP result disclosed to the patient

Patient has a primary caregiver willing to participate

Disqualifiers

Patient is only a carrier of a recessive variant that does not alone increase risk for cancer

Inability or unwillingness of patient or participating caregiver or to give informed consent/assent

Participating caregiver is under the age of 18 years

Patient or participating caregiver has evidence of significant cognitive deficits (per medical record) that would interfere with the ability to comprehend study questions

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

No trial groups listed